Seizure/Epilepsy Flashcards
acute management, chronic management, monitoring, DDI, ADE, pregnancy, peds, counseling points
drugs that can lower the seizure threshold
bupropion
clozapine
metoclopramide
theophylline
beta lactams
lithium
meperidine
FQs
tramadol
methadone
first line for acute seizure management
***if sz lasts >5 min
for 5-20 min
IV ativan or IV midazolam (versed) or rectal diazepam (Diastat)
for 20-40 min
give regular AEDs
keppra
VPA
IV fosphenytoin
IV phenytoin
phenobarbital
what doses does diastat (PR diazepam) come in
2.5mg
10mg
20mg
what is the device that can monitor sz in patients >6 yo
Embrace 2 smart watch
what type of diet can possible help with epilepsy
ketogenic
4:1 fats : carbs + proteins
what are the general coverage AEDs
keppra
lamotrigine
VPA
topiramate
how is lamotrigine dosed upon initiation for patients not on CYP inducers or inhibtors
week 1-2: 25mg po qd
week 2-4: 50mg po qd
week 5+: increase daily dose by 50mg q1-2 weeks
why is lamotrigine titrated slowly
risk of SJS/TEN
ADE of lamictal
SJS/TEN, DRESS, blood dyscrasias, arrhythmia, HLH, alopecia, N/V, somnolence, tremor, blurred vision
what color lamotrigine starter kit would be used for a patient on VPA
blue with a lower starting dose
what color lamotrigine starter kit would a patient use if they are not on any CYP inducers or inhibitors that affect lamotrigine
orange
what color lamotrigine starter kit would a patient be started on if they were taking a drug that induces CYP enzymes that affect lamotrigine concentrations and no VPA
green with a higher start dose
(phenobarbital, phenytoin, rifampin, SJW, primidone, carbamazepine)
levetiracetam dosing
start dose
MDD
renal adjustments?
what is the IV:PO ratio
start 500mg IR BID
MDD 3000mg
CrCl <80 –> dec dose
1:1
ADE of keppra
irritability, HTN, SJS/TEN, psych reactions, somnolence
levetiracetam DDI
no significant DDI :)
topiramate dosing
start dose
MDD
renal adjustments?
what is the IV:PO ratio
week 1: 25mg IR BID
week 2:-4: inc TDD by 50mg
week 5+: inc by 100mg weekly
MDD 400mg
CrCl <79 –> dec dose 50%
not available IV!
when is topiramate contraindicated
Er formulations are CI with alcohol and metformin
topiramate SE and monitoring
metabolic acidosis, nephrolithiasis, angle-closure glaucoma, memory issues, psychomotor slowing, anorexia, fetal harm
monitor bicarb, s/sx kidney stones, renal function (dec dose 50% if CrCl <80), hydration, eye exams for glaucoma
topiramate and CYP DDI
topiramate is a 3A4 inducer
3A4 inducers also dec topiramate levels
topiramate decreases efficacy of
estrogen-containing oral contraceptives and warfarin
what is the starting dose of VPA
15-20 mg/kg/day
MDD of VPA
60mg/kg/day
VPA concentrations are reported as
A. free
B. bound
C. total
C. total
VPA TDM goal
50-100mcg/mL of total VPA
what is the nuance with TDM of VPA
dec albumin will inc unbound VPA while VPA level stays the same bc it is total VPA
BBW of VPA
hepatic failure, fetal harm and neural tube defects
when is VPA contraindicated
hepatic disease
VPA SE and monitoring
SE: hyperammonemia, thrombocytopenia, DRESS
monitor: LFTs, CBC w diff, plts, TDM
T or F
carbapenems increase VPA concentrations
false, carbapenems dec VPA concentrations by induction
T or F
estrogen containing oral contraceptives decrease VPA concentrations
true, carbapenems do as well
T or F
VPA inhibits 2C9
true
T or F
VPA inhibits 2C19
false, VPA is a substrate of 2C19
what are the common inducers of VPA metabolism
phenytoin
phenobarbital
rifampin
carbamazepine
T or F
SJ Wort induces VPA metabolism
false, does not affect
which AEDs are metabolized by 2C19
VPA
lacosamide
phenytoin
esomeprazole and omeprazole will increase or decrease VPA concentrations? Which enzyme is involved?
esomeprazole and omeprazole inhibit CYP2C19 and will increase VPA concentrations